Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Ekins

Showing results (11-20 of 374) with videos related to

Pageof 38
Sort By:
Drug Discovery Today|October 9, 2016
Learning from the past for TB drug discovery in the futureKatarína Mikušová, Sean Ekins
Trends in Pharmacological Sciences|February 7, 2002
The PXR crystal structure: the end of the beginningSean Ekins, Erin Schuetz
Journal of Pharmacological and Toxicological Methods|February 24, 2010
Troubleshooting computational methods in drug discoverySandhya Kortagere, Sean Ekins
Pharmaceutical Research|January 24, 2009
A turning point for blood-brain barrier modelingSean Ekins, Alexander Tropsha
Journal of Molecular Graphics & Modelling|February 23, 2002
In silico ADME/Tox: the state of the artSean Ekins, John Rose
Pharmaceutical Research|December 16, 2015
Incentives for Starting Small Companies Focused on Rare and Neglected DiseasesSean Ekins, Jill Wood
Drug Discovery Today|October 20, 2009
Competitive collaboration in the pharmaceutical and biotechnology industryAlph Bingham, Sean Ekins
F1000Research|March 24, 2015
FDA approved drugs as potential Ebola treatmentsSean Ekins, Megan Coffee
Current Drug Metabolism|October 8, 2003
Prediction of human drug metabolizing enzyme inductionDayna C Mankowski, Sean Ekins
Drug Discovery Today|August 30, 2011
A quality alert and call for improved curation of public chemistry databasesAntony J Williams, Sean Ekins
Pageof 38

Showing results (11-20 of 374) with videos related to

Sort By:
Pageof 38
Drug Discovery Today|October 9, 2016
Learning from the past for TB drug discovery in the futureKatarína Mikušová, Sean Ekins
Trends in Pharmacological Sciences|February 7, 2002
The PXR crystal structure: the end of the beginningSean Ekins, Erin Schuetz
Journal of Pharmacological and Toxicological Methods|February 24, 2010
Troubleshooting computational methods in drug discoverySandhya Kortagere, Sean Ekins
Pharmaceutical Research|January 24, 2009
A turning point for blood-brain barrier modelingSean Ekins, Alexander Tropsha
Journal of Molecular Graphics & Modelling|February 23, 2002
In silico ADME/Tox: the state of the artSean Ekins, John Rose
Pharmaceutical Research|December 16, 2015
Incentives for Starting Small Companies Focused on Rare and Neglected DiseasesSean Ekins, Jill Wood
Drug Discovery Today|October 20, 2009
Competitive collaboration in the pharmaceutical and biotechnology industryAlph Bingham, Sean Ekins
F1000Research|March 24, 2015
FDA approved drugs as potential Ebola treatmentsSean Ekins, Megan Coffee
Current Drug Metabolism|October 8, 2003
Prediction of human drug metabolizing enzyme inductionDayna C Mankowski, Sean Ekins
Drug Discovery Today|August 30, 2011
A quality alert and call for improved curation of public chemistry databasesAntony J Williams, Sean Ekins
Pageof 38